General Surgery · Preview
A Newly Biopsied Gastric Lesion
General Surgery · Gastrointestinal oncology
An original surgical judgment case involving weight loss and biopsy-proven gastric adenocarcinoma. Work through evaluation, treatment choices and continuing care as new information becomes available.
Your five teaching phases
- 1. Surgical Assessment20 pts
Assess the surgical problem, urgency and patient-specific risks
- 2. Diagnostic Strategy25 pts
Choose investigations and explain how findings change management
- 3. Management and Operative Strategy25 pts
Defend treatment, operative decisions and reasonable alternatives
- 4. Complications and Rescue20 pts
Respond to the actual new event and reassess the response
- 5. Ongoing Care and Handoff10 pts
Plan monitoring, follow-up and transfer of responsibility
Speak or type your answers to the examiner, then review your saved feedback.
Content sources
- NCI Gastric Cancer Treatment PDQ, health professional version
- ESMO-adapted gastric cancer clinical guideline, 2024
- FDA durvalumab plus FLOT approval for resectable gastric cancer, November 2025
Original educational scenario. Source check: 2026-10-19. Surgeon validation pending. No official ABS scoring or exam outcome prediction.
Initial patient chart
Celia M., 64F
Weight loss and biopsy-proven gastric adenocarcinoma
Early satiety and 7-kg weight loss
- BP
- 122/74 mmHg
- HR
- 84/min
- BMI
- 22 kg/m²
- Early satiety and 7-kg weight loss
- Antral lesion on recent endoscopy
- Biopsy shows adenocarcinoma
- Independent in daily activities
Content reviewed: 2026-10-19